Invesco Advisers, Inc. - Net Worth and Insider Trading

Invesco Advisers, Inc. Net Worth

The estimated net worth of Invesco Advisers, Inc. is at least $71 Million dollars as of 2025-05-23. Invesco Advisers, Inc. is the 2102 Investment manager of Brii Biosciences Ltd and owns about 42,733,238 shares of Brii Biosciences Ltd (HKSE:02137) stock worth over $71 Million. Details can be seen in Invesco Advisers, Inc.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Invesco Advisers, Inc. has not made any transactions after 2023-02-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Invesco Advisers, Inc.

To

Invesco Advisers, Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Invesco Advisers, Inc. owns 1 companies in total, including Brii Biosciences Ltd (HKSE:02137) .

Click here to see the complete history of Invesco Advisers, Inc.’s form 4 insider trades.

Insider Ownership Summary of Invesco Advisers, Inc.

Ticker Company Transaction Date Type of Owner
HKSE:02137 Brii Biosciences Ltd 2023-02-06 2102 Investment manager

Invesco Advisers, Inc. Latest Holdings Summary

Invesco Advisers, Inc. currently owns a total of 1 stock. Invesco Advisers, Inc. owns 42,733,238 shares of Brii Biosciences Ltd (HKSE:02137) as of February 6, 2023, with a value of $71 Million.

Latest Holdings of Invesco Advisers, Inc.

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:02137 Brii Biosciences Ltd 2023-02-06 42,733,238 1.67 71,364,507

Holding Weightings of Invesco Advisers, Inc.


Invesco Advisers, Inc. Form 4 Trading Tracker

According to the SEC Form 4 filings, Invesco Advisers, Inc. has made a total of 2 transactions in Brii Biosciences Ltd (HKSE:02137) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Brii Biosciences Ltd is the sale of 3,733,500 shares on February 6, 2023, which brought Invesco Advisers, Inc. around $47 Million.

Insider Trading History of Invesco Advisers, Inc.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Invesco Advisers, Inc. Trading Performance

GuruFocus tracks the stock performance after each of Invesco Advisers, Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Invesco Advisers, Inc. is -62.31%. GuruFocus also compares Invesco Advisers, Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Invesco Advisers, Inc. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Invesco Advisers, Inc.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Invesco Advisers, Inc.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -55.31 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -51.15 LIMIT LIMIT LIMIT LIMIT LIMIT

Invesco Advisers, Inc. Ownership Network

Ownership Network List of Invesco Advisers, Inc.

No Data

Ownership Network Relation of Invesco Advisers, Inc.

Insider Network Chart


Invesco Advisers, Inc. Owned Company Details

What does Brii Biosciences Ltd do?

Who are the key executives at Brii Biosciences Ltd?

Invesco Advisers, Inc. is the 2102 Investment manager of Brii Biosciences Ltd. Other key executives at Brii Biosciences Ltd include 2201 Interest of corporation controlled by you Xyxy Holdings Ltd. , 2101 Beneficial owner Booming Passion Limited , and 2201 Interest of corporation controlled by you Boyu Capital Fund III, L.P. .

Brii Biosciences Ltd (HKSE:02137) Insider Trades Summary

Over the past 18 months, Invesco Advisers, Inc. made no insider transaction in Brii Biosciences Ltd (HKSE:02137). Other recent insider transactions involving Brii Biosciences Ltd (HKSE:02137) include a net purchase of 363,250 shares made by Hong Zhi , a net sale of 0 shares made by Boyu Capital Group Holdings Ltd , and a net sale of 0 shares made by Tong Xiaomeng .

In summary, during the past 3 months, insiders sold 0 shares of Brii Biosciences Ltd (HKSE:02137) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Brii Biosciences Ltd (HKSE:02137) were sold and 363,250 shares were bought by its insiders, resulting in a net purchase of 363,250 shares.

Brii Biosciences Ltd (HKSE:02137)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Brii Biosciences Ltd Insider Transactions

No Available Data

Invesco Advisers, Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for Invesco Advisers, Inc.. Currently GuruFocus does not have mailing address information for Invesco Advisers, Inc..